A German delegation consisting of scientists and senior executives from leading biomedical and biotechnology companies embarked on a visit to China on Thursday. The visit, scheduled from June 27 to July 3, aims to strengthen ties and explore avenues for enhanced cooperation between the two countries.
Organized by the China International Investment Promotion Agency (Germany), the German office of China’s Ministry of Commerce, the itinerary includes visits to major biomedical industry bases and enterprises across China. This provides the German companies with an opportunity to gain firsthand insights into China’s latest products, technological advancements, and innovative practices in the biomedical industry.
This visit signifies a growing interest among German biomedical firms in the Chinese market, reflecting the potential for collaborative innovation and mutual growth. As China continues to make significant strides in biomedical research and development, partnerships with German companies could lead to advancements benefiting both nations and the global community.
The delegation’s itinerary is designed to foster understanding and pave the way for future collaborative projects. By engaging directly with Chinese enterprises, the German delegation can identify areas of mutual interest and explore possibilities for joint ventures, research collaborations, and technology exchange.
The visit underscores the importance of international cooperation in the biomedical field, particularly in the wake of global health challenges that require concerted efforts and shared expertise. Strengthening ties between Germany and China in this sector holds promise for innovative solutions and advancements in healthcare worldwide.
Reference(s):
German biomedical delegation voices confidence in Chinese market
cgtn.com
